General MedicationsORALGeneric
DIDANOSINE
DIDANOSINE
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview DIDANOSINE is listed in Drugs@FDA under application 077275 (ANDA).
Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength TABLET, FOR SUSPENSION;ORAL - 100MG Sponsor AUROBINDO Submission history Latest submission status date: 2012-08-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIDANOSINE is listed in Drugs@FDA under application 077275 (ANDA). Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength TABLET, FOR SUSPENSION;ORAL - 100MG Sponsor AUROBINDO Submission history Latest submission status date: 2012-08-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.